Xinru Mao
Company: Burning Rock Biotech
Job title: Vice President - Biomarker and Companion Diagnostics Services
Seminars:
Navigating MRCT Study & NGS-Based CDx Development Strategies: A Global View 12:30 pm
The Value of NGS-Based Solutions in Clinical Study on Precision Medicine has significant advantages. NGS-Based CDx Development in different countries require diverse strategies for development and registration. Challenges and solutions we are facing during the CDx development and our strategiesRead more
day: Conference Day Two - Track 2